Itraconazole (130 mg) & CONARIS SB 130 : Buy Sterispharma Medicines: Quality You Can Trust....

CONARIS SB 130 

Itraconazole (130 mg)

CONARIS SB 130, featuring Itraconazole 130 mg, is a powerful antifungal medication designed to combat a wide range of fungal infections. This detailed guide explores the benefits, uses, dosage guidelines, and safety information associated with CONARIS SB 130, helping patients and healthcare providers understand its significant role in fungal infection management.

Understanding Itraconazole (130 mg):

Itraconazole, the active ingredient in CONARIS SB 130, is a triazole antifungal agent that works by inhibiting the synthesis of ergosterol, a key component of fungal cell membranes. Without ergosterol, the fungal cells become defective and eventually die, effectively stopping the infection from spreading.

Uses of CONARIS SB 130:

CONARIS SB 130 is primarily used to treat various fungal infections, including:

1. Candidiasis: Infections caused by Candida species, which can affect the mouth, throat, skin, and other areas.
2. Blastomycosis and Histoplasmosis: Fungal infections that can affect the lungs and other parts of the body.
3. Onychomycosis: A fungal infection that affects the toenails or fingernails, causing the nails to thicken, discolor, and possibly split.

Dosage and Administration:

The recommended dosage of CONARIS SB 130 depends on the type and severity of the fungal infection being treated. It is typically administered as a single daily dose, taken with food to enhance absorption. The duration of the treatment varies according to the specific fungal infection and the patient's response to the medication. Patients are advised to follow their healthcare provider's instructions closely to ensure optimal effectiveness and safety.

Benefits of CONARIS SB 130:

1. Broad-Spectrum Antifungal Action: CONARIS SB 130 is effective against a wide array of fungal pathogens, making it a versatile choice for treating diverse fungal infections.
2. Targeted Therapy: Itraconazole targets the fungal cells directly, minimizing damage to human cells and reducing the risk of side effects.
3. Convenient Dosage Form: The 130 mg formulation allows for convenient dosing and adherence to treatment regimens, facilitating better patient compliance.

Potential Side Effects:

While CONARIS SB 130 is generally safe and effective, some patients may experience side effects such as:

• Nausea and vomiting
• Headache
• Dizziness
• Abdominal pain
• Rash
• Elevated liver enzymes, which may indicate liver injury

Patients should monitor their health and report any adverse effects to their healthcare provider immediately.

Conclusion:

CONARIS SB 130 offers a robust solution for managing and treating various fungal infections. Its potent antifungal action, combined with a convenient dosing schedule, makes it a preferred choice for patients seeking effective fungal infection treatment. By adhering to dosage instructions and monitoring for side effects, patients can achieve optimal outcomes while minimizing risks. For those struggling with persistent fungal infections, CONARIS SB 130 provides a reliable and effective treatment pathway, paving the way for a healthier, infection-free life. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW